Nanoparticles could improve effectiveness of cancer immunotherapy

Written by Rhiannon Finnie (Future Science Group)

nanoparticle immunotherapy cancer

Researchers from Massachusetts Institute of Technology (MIT; MA, USA) have developed a novel nanoparticle that can increase the effectiveness of a type of immunotherapy cancer therapy. The team demonstrated that treating mice with existing drugs – termed checkpoint inhibitors – with their nanoparticles was more effective at treating cancer than when just the drug was used alone. These results could allow for cancer immunotherapy to benefit a greater percentage of patients as they are currently only effective for a small portion. The human immune system is capable of recognizing and destroying abnormal cells such as cancer cells. However, many tumors...

To view this content, please register now for access

It's completely free